Replies to post #187385 on Amarin Corp Plc (AMRN)

[Biobillionair]

Thanks Sam! Appreciate all the hard work!! Eventually these sales numbers with drive AMRN PPS, I look forward to 2019 Q1.—BB

[Megc]

Thanks Sam for the great data!

[tm100]

Thanks Sam.

I continue to be confused by the number of refills. Seems it should be greater than NRx by a large margin. I must not understand the definition of a refill and an NRx. L and Generic L follow the same pattern. So my assumptions about a refill must be flawed.

Can someone educate me?

Or do that many people fail to continue the prescription? I find that difficult to believe.

[invest2992]

Sam, thanx for posting Amarin scripts. They are very encouraging and this is before the impact of the SOC of the ADA! Can’t wait until we have the lions share of this market and we begin to report positive EPS. BUT I’m not sure which series I should focus on, normalized non-normalized, randomized, non-randomized. Makes my poor little brain spin.

[biotech_researcher]

There are now 330 million shares outstanding (I did not include the additional shares from options and I should have), and I’m trying to model the additional shares that will be issued in 2019 (dilution) to grow the business. Any estimates? They are going to need a lot of cash as this is really going to ramp.

[Restingzebra]

You're right Sam: Amazing numbers! As always, thanks for posting these and all you do.

[mrmainstreet]

Thanks Sam. Now it's time to grow the overall market size not just the market share.

[moonotaur]

Assuming each script contributes $130 in sales to Amarin and assuming ZERO growth in scripts the rest of the year, the $350M revenue target provided by mgmt was just reached with this last data.

Q1 Rx = 623,715

plus (9 * 229,525) (remaining months * March Rx)

= 2,689,440 Normalized RX for 2019

2,689,440 * 130 = $349,627,200

[BioChica]

Amazing numbers and expected now that we have a winning drug!

Thanks!

[massulo52]

Great job Sam, fantastic numbers